Battered -- But Not Beaten -- Pharmaceutical-Biotech Industry Offers Up Over $14 Billion in Capital and Maintenance Project Starts for 2005, an Advisory from Industrialinfo.com.

HOUSTON -- Researched by Industrialinfo.com (Industrial Information Resources (1) The data and information assets of an organization, department or unit. See data administration.

(2) Another name for the Information Systems (IS) or Information Technology (IT) department. See IT. , Incorporated; Houston, Texas “Houston” redirects here. For other uses, see Houston (disambiguation).
Houston (pronounced /'hjuːstən/) is the largest city in the state of Texas and the ). As 2005 heads into the second quarter, the Pharmaceutical-Biotech industry still finds itself the poster child as the one business the public can't live with, but most certainly can't live without! In a year thus far filled with issues, including an alarming number of product failures, and with the drug reimportation re·im·port
tr.v. re·im·port·ed, re·im·port·ing, re·im·ports
To bring back into a country (goods made from its exported raw materials).

re·im issue still unresolved Not completed; not finished; not linked together. See resolve. , it's anybody's guess how the rest of 2005 will pan out for the industry's public image. Yet, the fact remains that serious dollars are still being spent to develop and produce the life enhancing and often, life saving, drugs America craves.

For details on this development view the entire article at www.industrialinfo.com.

Industrialinfo.com is the leading provider of global industrial market research. We specialize in helping companies develop information solutions to maximize their sales and marketing efforts.

COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Apr 19, 2005
Words:	145
Previous Article:	BASF Selects Engineer for Major Project in Texas, an Advisory from Industrialinfo.com.
Next Article:	Hazelden Foundation to Be Honored for Their Own Charitable Donation to the Doe Fund's Job Skills Training Program.

Related Articles
$140 Billion Pharmaceutical Industry Poised for a 10% Sales Growth in 2002, Dictating an Increase in Capital Spending, in an Advisory by...
Industrialinfo.com Releases 2004 North American Pharmaceutical-Biotech Forecast Identifying Over $13 Billion in Capital and MRO Spending.
Prescription for Profit: Industrialinfo.com's 2004 North American Pharmaceutical-Biotech Forecast Tracks Over $13 Billion in Project Spending.
Pharma Snapshot: $4 Billion North American Capital Project Spending Summary for June 2004, an Advisory from Industrialinfo.com.
Pharma Update: 2004 Pharmaceutical-Biotech Forecast Features Revised Top 20 Companies Representing $6 Billion Investment in Project Spending, an...
Quarterly Update Reveals Healthy $11 Billion Being Invested in 2004 for North American Pharmaceutical-Biotech Industry Capital Projects, an Advisory...
Prescription for Profit: 2005 Pharmaceutical-Biotech Industry Forecast Reveals Over $13 billion for Capital/MRO Projects in 2005, an Advisory from...
Over 950 Exhibitors Expected at INTERPHEX2005 -- World's Largest Pharmaceutical Show April 26-28, 2005 in NYC, an Advisory from Industrialinfo.com.
Drama Aside -- Pharmaceutical-Biotech Industry Diagnosed for Healthy Investment of Nearly $13 Billion in 2005 North American Project Activity, an...